Legal Representation
Attorney
Belinda A. Boyer
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 3, 2006 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 3, 2006 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 2, 2006 | GNCF | O | CONTINUATION OF FINAL REFUSAL E-MAILED | Loading... |
| Apr 2, 2006 | CNCF | R | ACTION CONTINUING A FINAL - COMPLETED | Loading... |
| Feb 15, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jan 30, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 30, 2006 | I | PAPER RECEIVED | Loading... | |
| Jul 28, 2005 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 28, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 26, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jun 7, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 7, 2005 | FAXX | I | FAX RECEIVED | Loading... |
| Dec 7, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2004 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 29, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 6, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
(Based on Intent to Use) Chemical, biochemical, biological, biotechnological products and preparations not including agarose, namely free radical and reactive oxygen species catalyst products, namely, compounds that mimic the catalytic activity of superoxide dismutase, intended for the pharmaceutical industry and for the sciences, other than for medical or veterinary use; chemical, biochemical, biological, biotechnological products not including agarose, namely free radical and reactive oxygen species catalyst products, namely, compounds that mimic the catalytic activity of superoxide dismutase for laboratory analyses, other than for medical or veterinary use; biochemicals namely, free radical and reactive oxygen species catalysts for in vitro use; biochemicals not including agarose namely, free radical and reactive oxygen species catalyst precursors for in vitro use; biochemicals not including agarose namely, free radical and reactive oxygen species catalyst metabolites for in vitro use; and chemical reagents not including agarose for scientific or research use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
(Based on Intent to Use) Pharmaceutical preparations not including agarose for the treatment of pain, inflammation and inflammatory diseases, cancer, degenerative diseases including cartilage degeneration and nenrodegeneration, cardiovascular diseases, autoimmune diseases including arthritis, diseases of the skin and epidermis, ocular diseases, veterinary diseases; and chemotherapeutic preparations not including agarose for use in chemotherapy
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
(Based on Use in Commerce) Technical consultation and research in biology, pharmacology, biology, biotechnology, pharmacy, and medicine, namely consultation and research in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose; providing information in the fields of biology, biotechnology, pharmacy, and medicine, namely providing information on the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose all for research and development purposes; research and development of new products for others in the fields of pharmacy, biology and biotechnology, medicine and the sciences, namely research and development for others in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose; and laboratory research in the fields of biology, biotechnology, pharmacy, and medicine and the sciences, namely laboratory research in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose
First Use Anywhere:
Jun 12, 2003
First Use in Commerce:
Jun 12, 2003
Class 044
(Based on Use in Commerce) Providing information in the fields of biology, biotechnology, pharmacy, and medicine, namely providing information on the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst constructs, catalyst precusors and catalyst metabolites not including agarose all for treatment and diagnosis purposes
First Use Anywhere:
Jun 12, 2003
First Use in Commerce:
Jun 12, 2003
Additional Information
Design Mark
The mark consists of Metaphore and arch design in the color blue. The color blue is claimed as a feature of the mark, and the color blue appears in the word Metaphore and in the arch design.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
001
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"